Submission of Intimation of Outcome of EGM held on 09th January, 2026.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Novelix Pharmaceuticals Limited (formerly Trimurthi Limited) held its Extra Ordinary General Meeting on 09th January 2026 via video conferencing, from 3:30 PM to 3:56 PM, attended by 64 members. Two items of business were transacted: (1) a Special Resolution for the issue of equity shares on a preferential basis, and (2) an Ordinary Resolution to confirm the appointment of Ms. Sridevi Belide (DIN: 10455373) as a Non-Executive Non-Independent Director. Remote e-voting was conducted from 06th to 08th January 2026, with Mr. Bharat Khaniwal appointed as the scrutinizer. The actual voting results have not been disclosed in this filing and will be announced separately within 48 hours of the meeting's conclusion.
Shareholders should watch for the voting results, expected within 48 hours. If approved, the preferential share issue could dilute existing shareholding, while the new director appointment adds to the board. Pending outcome, the stock price reaction will depend on the results and terms of the preferential allotment.